Immatics Biotechnologies Market Capitalization vs. Total Debt
| IMTXW Stock | USD 0.50 0.10 25.00% |
Immatics Biotechnologies Market Cap |
|
For Immatics Biotechnologies profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Immatics Biotechnologies to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well immatics biotechnologies GmbH utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Immatics Biotechnologies's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of immatics biotechnologies GmbH over time as well as its relative position and ranking within its peers.
Immatics |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics Biotechnologies. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.766 | Quarterly Revenue Growth (0.16) | Return On Assets (0.12) | Return On Equity (0.24) |
The market value of Immatics Biotechnologies is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Immatics Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics Biotechnologies' market value can be influenced by many factors that don't directly affect Immatics Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immatics Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immatics Biotechnologies Total Debt vs. Market Capitalization Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Immatics Biotechnologies's current stock value. Our valuation model uses many indicators to compare Immatics Biotechnologies value to that of its competitors to determine the firm's financial worth. immatics biotechnologies GmbH is rated second overall in market capitalization category among its peers. It also is rated second overall in total debt category among its peers making up about 0.02 of Total Debt per Market Capitalization. The ratio of Market Capitalization to Total Debt for immatics biotechnologies GmbH is roughly 43.70 . At this time, Immatics Biotechnologies' Market Cap is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Immatics Biotechnologies by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Immatics Market Capitalization vs. Competition
immatics biotechnologies GmbH is rated second overall in market capitalization category among its peers. Market capitalization of Health Care industry is currently estimated at about 2.7 Billion. Immatics Biotechnologies totals roughly 673 Million in market capitalization claiming about 25% of equities under Health Care industry.
Immatics Total Debt vs. Market Capitalization
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Immatics Biotechnologies |
| = | 673 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Immatics Biotechnologies |
| = | 15.4 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Immatics Total Debt vs Competition
immatics biotechnologies GmbH is rated second overall in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 229.99 Million. Immatics Biotechnologies holds roughly 15.4 Million in total debt claiming about 7% of equities under Health Care industry.
Immatics Biotechnologies Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Immatics Biotechnologies, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Immatics Biotechnologies will eventually generate negative long term returns. The profitability progress is the general direction of Immatics Biotechnologies' change in net profit over the period of time. It can combine multiple indicators of Immatics Biotechnologies, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.6 M | -1.7 M | |
| Net Interest Income | 13 M | 13.7 M | |
| Interest Income | 13.8 M | 14.5 M | |
| Operating Income | -101.7 M | -96.6 M | |
| Net Loss | -97 M | -101.8 M | |
| Income Before Tax | -97 M | -101.8 M | |
| Total Other Income Expense Net | 4.7 M | 5 M | |
| Net Loss | -97 M | -101.8 M | |
| Income Tax Expense | 831 K | 573.8 K | |
| Net Loss | (1.20) | (1.26) | |
| Income Quality | (0.19) | (0.18) | |
| Net Income Per E B T | 1.03 | 1.07 |
Immatics Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Immatics Biotechnologies. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Immatics Biotechnologies position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Immatics Biotechnologies' important profitability drivers and their relationship over time.
Use Immatics Biotechnologies in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immatics Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immatics Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Immatics Biotechnologies Pair Trading
immatics biotechnologies GmbH Pair Trading Analysis
The ability to find closely correlated positions to Immatics Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immatics Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immatics Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling immatics biotechnologies GmbH to buy it.
The correlation of Immatics Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immatics Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immatics Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immatics Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Immatics Biotechnologies position
In addition to having Immatics Biotechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Municipals ETFs Thematic Idea Now
Broad Municipals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Municipals ETFs theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Municipals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Immatics Stock Analysis
When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.